Cannabix Technologies Inc. (BLOZF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cannabix Technologies Inc. (BLOZF) with AI Score 51/100 (Hold). Cannabix Technologies Inc. specializes in developing marijuana breathalyzer technology for law enforcement and employers. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Cannabix Technologies Inc. (BLOZF) Healthcare & Pipeline Overview
Cannabix Technologies Inc. is a technology company focused on developing marijuana breathalyzers for rapid detection of recent cannabis use. Targeting employers, law enforcement, and the public in North America, the company aims to provide point-of-care breath testing solutions in the evolving cannabis market.
Investment Thesis
Cannabix Technologies Inc. presents a speculative investment opportunity in the emerging cannabis detection market. The company's focus on developing marijuana breathalyzer technology addresses a growing need for accurate and rapid cannabis impairment detection. Key value drivers include the potential adoption of their breathalyzer technology by law enforcement and employers, driven by increasing cannabis legalization and the need for workplace safety. The company's negative P/E ratio of -14.93 and a negative profit margin of -5141.5% indicate that the company is not yet profitable, highlighting the speculative nature of the investment. The high beta of 1.61 suggests high volatility relative to the market. Upcoming catalysts include potential partnerships with law enforcement agencies and regulatory approvals for their breathalyzer technology. The primary risk factor is the uncertainty of market adoption and competition from alternative cannabis detection methods.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.07 billion reflects the company's small size and speculative nature within the cannabis technology sector.
- P/E Ratio of -14.93 indicates the company is currently unprofitable, typical for early-stage technology companies.
- Profit Margin of -5141.5% highlights significant expenses relative to revenue, reflecting ongoing research and development costs.
- Gross Margin of -67.8% suggests challenges in achieving profitability from current product offerings.
- Beta of 1.61 indicates higher volatility compared to the overall market, common for companies in emerging sectors.
Competitors & Peers
Strengths
- Proprietary breathalyzer technology for rapid cannabis detection.
- Focus on the growing market for cannabis impairment testing.
- Potential for partnerships with law enforcement and employers.
- Experienced management team with expertise in technology development.
Weaknesses
- Limited revenue and profitability.
- Dependence on regulatory approvals and market adoption.
- Competition from established players in the drug testing industry.
- High operating expenses related to research and development.
Catalysts
- Upcoming: Potential partnerships with law enforcement agencies for field testing of breathalyzer technology.
- Upcoming: Regulatory approvals for the commercial sale of breathalyzer devices in key markets.
- Ongoing: Increasing adoption of cannabis testing programs by employers and government agencies.
- Ongoing: Expansion of cannabis legalization and regulation across North America.
- Upcoming: Results from ongoing clinical trials and validation studies of breathalyzer accuracy.
Risks
- Potential: Competition from alternative cannabis detection methods, such as blood and saliva tests.
- Potential: Changes in cannabis regulations that could impact the demand for breathalyzer technology.
- Ongoing: Dependence on regulatory approvals and market acceptance of breathalyzer devices.
- Ongoing: Limited financial resources and potential need for additional funding.
- Potential: Technological advancements that could render their breathalyzer technology obsolete.
Growth Opportunities
- Expansion into Law Enforcement: Cannabix has a significant growth opportunity in supplying law enforcement agencies with its breathalyzer technology. As cannabis legalization spreads, law enforcement requires tools to accurately and quickly detect impaired drivers. Securing contracts with police departments and highway patrols across North America could drive substantial revenue growth. The market size for law enforcement cannabis detection is estimated to be worth tens of millions of dollars annually, with potential for further expansion as regulations evolve.
- Workplace Safety Programs: The company can capitalize on the growing demand for workplace safety solutions related to cannabis use. Employers are increasingly seeking methods to ensure employees are not impaired while on the job. Cannabix's breathalyzer technology offers a convenient and non-invasive solution for workplace testing. Targeting industries such as transportation, construction, and manufacturing could provide a significant revenue stream. The market for workplace cannabis testing is projected to reach hundreds of millions of dollars in the coming years.
- Partnerships with Insurance Companies: Collaborating with insurance companies to offer incentives for using cannabis detection technology could drive adoption and revenue. Insurance companies may offer discounts to companies that implement regular cannabis testing programs, creating a demand for Cannabix's breathalyzer technology. This partnership strategy could provide a steady stream of revenue and increase market penetration. The insurance industry's involvement in promoting safety and risk management creates a favorable environment for this growth opportunity.
- International Expansion: While currently focused on North America, Cannabix has the potential to expand its market reach internationally. As cannabis legalization spreads to other countries, the demand for cannabis detection technology will likely increase globally. Entering markets in Europe, South America, and Australia could provide significant growth opportunities. Adapting the breathalyzer technology to meet international regulatory standards will be crucial for successful expansion. The global market for cannabis detection is expected to grow substantially in the coming decade.
- Development of Advanced Detection Technology: Investing in research and development to enhance the accuracy and reliability of its breathalyzer technology is crucial for long-term growth. Developing new features, such as the ability to detect specific levels of THC or identify different strains of cannabis, could provide a competitive advantage. Continuous innovation will be essential to maintaining market leadership and attracting new customers. The market for advanced cannabis detection technology is expected to grow as regulations become more sophisticated.
Opportunities
- Expansion into new markets and applications for breathalyzer technology.
- Development of advanced features and capabilities for cannabis detection.
- Strategic alliances with insurance companies and healthcare providers.
- Increased awareness and acceptance of cannabis impairment testing.
Threats
- Changes in cannabis regulations and laws.
- Technological advancements that could render their technology obsolete.
- Competition from alternative cannabis detection methods.
- Economic downturns that could reduce demand for cannabis testing services.
Competitive Advantages
- Proprietary breathalyzer technology provides a competitive advantage in the cannabis detection market.
- Focus on rapid, point-of-care testing offers a convenient alternative to traditional methods.
- Established relationships with key stakeholders in the law enforcement and employer sectors.
- First-mover advantage in the emerging market for marijuana breathalyzer technology.
About BLOZF
Cannabix Technologies Inc., formerly known as West Point Resources Inc., was incorporated in 2011 and rebranded in August 2014 to focus on the emerging cannabis detection technology sector. Based in Burnaby, Canada, the company develops tetrahydrocannabinol (THC) breath analyzers designed for employers, law enforcement, governments, and the general public. Their primary product is a point-of-care breath testing tool that allows for the rapid detection of recent cannabis use through breath samples. This technology aims to provide a non-invasive and immediate method for identifying individuals who may be under the influence of cannabis. Cannabix also develops breath collection units to support their breathalyzer technology. The company's focus is on the North American market, where cannabis legalization and regulation are rapidly evolving, creating a demand for reliable and accurate cannabis detection methods. Cannabix Technologies positions itself as a key player in providing solutions for ensuring workplace safety and public safety in the context of increasing cannabis use.
What They Do
- Develop marijuana breathalyzer technology.
- Create point-of-care breath testing tools for rapid detection of recent cannabis use.
- Offer solutions for employers, law enforcement, governments, and the public.
- Manufacture tetrahydrocannabinol (THC) breath analyzers.
- Produce breath collection units for use with their breathalyzer devices.
- Focus on the North American market for cannabis detection solutions.
Business Model
- Sales of marijuana breathalyzer devices to employers, law enforcement, and government agencies.
- Recurring revenue through the sale of breath collection units and related consumables.
- Partnerships with distributors and resellers to expand market reach.
- Potential licensing agreements for their breathalyzer technology.
Industry Context
Cannabix Technologies operates within the rapidly evolving cannabis industry, specifically in the niche market of cannabis detection technology. The increasing legalization of cannabis in North America is driving demand for accurate and reliable methods of detecting cannabis impairment. The competitive landscape includes companies developing alternative cannabis detection methods, such as blood and saliva tests. Cannabix aims to differentiate itself through its breathalyzer technology, offering a non-invasive and immediate solution. The market for cannabis detection technology is expected to grow significantly as regulations evolve and the need for workplace and public safety increases.
Key Customers
- Employers seeking to maintain workplace safety and prevent cannabis-related incidents.
- Law enforcement agencies requiring tools to detect impaired drivers and enforce cannabis laws.
- Government agencies responsible for regulating cannabis use and ensuring public safety.
- Public sector organizations involved in drug testing and monitoring programs.
Financials
Chart & Info
Cannabix Technologies Inc. (BLOZF) stock price: Price data unavailable
Latest News
No recent news available for BLOZF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BLOZF.
Price Targets
Wall Street price target analysis for BLOZF.
MoonshotScore
What does this score mean?
The MoonshotScore rates BLOZF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Ravinder S. Mlait
CEO
Ravinder S. Mlait serves as the CEO of Cannabix Technologies Inc. His background encompasses extensive experience in technology development and management, with a focus on bringing innovative products to market. Mlait has a proven track record in leading technology companies through various stages of growth, from early-stage development to commercialization. His expertise includes strategic planning, product development, and market penetration. He is responsible for overseeing the company's overall strategy and operations, driving the development and commercialization of Cannabix's marijuana breathalyzer technology.
Track Record: Under Ravinder S. Mlait's leadership, Cannabix Technologies Inc. has focused on advancing its breathalyzer technology and securing key partnerships. He has overseen the development and testing of the company's point-of-care breath testing tool, aimed at providing a rapid and accurate method for detecting recent cannabis use. Mlait has also focused on building relationships with law enforcement agencies and employers to drive adoption of the company's technology. His strategic decisions have been instrumental in positioning Cannabix as a key player in the emerging cannabis detection market.
BLOZF OTC Market Information
The OTC Other tier, where Cannabix Technologies Inc. trades, represents the lowest tier of the OTC market. Companies in this tier often do not meet the minimum financial standards required for listing on major exchanges like the NYSE or NASDAQ. These companies may have limited operating history, be in early stages of development, or face financial challenges. Unlike companies on higher OTC tiers (OTCQX and OTCQB), OTC Other companies have minimal listing requirements and may not be required to provide audited financial statements. This lack of stringent requirements increases the risk associated with investing in these companies compared to those listed on regulated exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: The lack of mandatory financial reporting requirements increases the risk of investing in BLOZF.
- Low Liquidity: The low trading volume can make it difficult to buy or sell shares without affecting the price.
- Price Volatility: OTC stocks are often more volatile than those listed on major exchanges.
- Regulatory Uncertainty: Changes in OTC market regulations could impact the company's trading status.
- Limited Operating History: As a relatively young company, BLOZF has a limited track record to assess its long-term viability.
- Verify the company's financial statements and audit reports.
- Assess the company's business plan and market opportunity.
- Evaluate the management team's experience and track record.
- Review the company's legal and regulatory filings.
- Monitor the trading volume and bid-ask spread of BLOZF shares.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has a functional website with detailed information about its products and services.
- Cannabix Technologies Inc. has patents or pending patents for its breathalyzer technology.
- The company has established partnerships with law enforcement agencies or employers.
- The management team has relevant experience in the technology and cannabis industries.
- The company has received positive media coverage or industry recognition.
Cannabix Technologies Inc. Stock: Key Questions Answered
What does Cannabix Technologies Inc. do?
Cannabix Technologies Inc. specializes in developing and commercializing marijuana breathalyzer technology for detecting recent cannabis use. Their primary product is a point-of-care breath testing tool designed to provide rapid and accurate results for employers, law enforcement, and other organizations. The company focuses on creating non-invasive and convenient solutions for identifying individuals who may be under the influence of cannabis, addressing the growing need for impairment detection in the context of increasing cannabis legalization. Cannabix aims to be a leading provider of cannabis breathalyzer technology in the North American market.
What do analysts say about BLOZF stock?
As of 2026-03-18, there is no readily available analyst consensus on BLOZF stock due to its OTC listing and speculative nature. Key valuation metrics such as P/E ratio (-14.93) and profit margin (-5141.5%) indicate that the company is not yet profitable. Growth considerations revolve around the potential adoption of their breathalyzer technology by law enforcement and employers, driven by increasing cannabis legalization. Investors should conduct thorough due diligence and consider the risks associated with investing in early-stage technology companies on the OTC market.
What are the main risks for BLOZF?
The main risks for Cannabix Technologies Inc. include competition from alternative cannabis detection methods, such as blood and saliva tests, and potential changes in cannabis regulations that could impact the demand for their breathalyzer technology. The company is also dependent on regulatory approvals and market acceptance of their breathalyzer devices. Limited financial resources and the potential need for additional funding pose a risk to their ability to execute their business plan. Additionally, technological advancements could render their breathalyzer technology obsolete, requiring continuous innovation and investment in research and development.
What are the key factors to evaluate for BLOZF?
Cannabix Technologies Inc. (BLOZF) currently holds an AI score of 51/100, indicating moderate score. Key strength: Proprietary breathalyzer technology for rapid cannabis detection.. Primary risk to monitor: Potential: Competition from alternative cannabis detection methods, such as blood and saliva tests.. This is not financial advice.
How frequently does BLOZF data refresh on this page?
BLOZF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BLOZF's recent stock price performance?
Recent price movement in Cannabix Technologies Inc. (BLOZF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary breathalyzer technology for rapid cannabis detection.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BLOZF overvalued or undervalued right now?
Determining whether Cannabix Technologies Inc. (BLOZF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BLOZF?
Before investing in Cannabix Technologies Inc. (BLOZF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC market data may be less reliable than data from major exchanges.
- Financial information is limited due to the company's OTC listing.